fulvestrant has been researched along with transforming growth factor alpha in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blamey, RW; Francis, AB; Gee, JM; McClelland, RA; Nicholson, RI; Robertson, JF; Wakeling, AE | 1 |
| Cho, E; Hilakivi-Clarke, L; Kenney, N; Raygada, M | 1 |
| Catherino, WH; Jordan, VC; Levenson, AS | 1 |
| Jordan, VC; Levenson, AS; Tonetti, DA | 1 |
| Bentrem, DJ; Jordan, VC; Liu, H; MacGregor Schafer, J; Zapf, JW | 1 |
| Jordan, VC; Liu, H; Pearce, ST | 1 |
| Farnell, YZ; Ing, NH | 1 |
| Chen, B; Gajdos, C; Jordan, VC; Liu, H; Osipo, C | 1 |
| Greene, AL; Kundel, DW; Kundel, KD; Regal, RR; Rose-Hellekant, TA; Skildum, AJ; Zhdankin, O | 1 |
| Greene, GL; Jallow, F; O'Leary, KA; Rugowski, DE; Schuler, LA; Sinkevicius, KW; Sullivan, R | 1 |
10 other study(ies) available for fulvestrant and transforming growth factor alpha
| Article | Year |
|---|---|
Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancer.
Topics: Breast Neoplasms; ErbB Receptors; Estradiol; Estrogen Antagonists; Female; Frozen Sections; Fulvestrant; Humans; Immunohistochemistry; Postmenopause; Receptors, Estrogen; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1996 |
Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182,780.
Topics: Adipose Tissue; Animals; Animals, Newborn; Buffers; Epithelial Cells; Epithelium; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Mammary Glands, Animal; Mice; Mice, Inbred Strains; Oils; Phosphates; Pregnancy; Receptors, Estrogen; Transforming Growth Factor alpha | 1997 |
Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor.
Topics: Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mutation; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; RNA, Neoplasm; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1997 |
The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor.
Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Humans; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Transforming Growth Factor alpha | 1998 |
Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
Topics: Allosteric Regulation; Amino Acid Substitution; Aspartic Acid; Binding Sites; Drug Interactions; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Glycine; Humans; Kinetics; Ligands; Mutagenesis, Site-Directed; Protein Conformation; Protein Structure, Tertiary; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2000 |
Modulation of estrogen receptor alpha function and stability by tamoxifen and a critical amino acid (Asp-538) in helix 12.
Topics: Aspartic Acid; Blotting, Northern; Blotting, Western; Cell Line; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Humans; Ligands; Luciferases; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Time Factors; Transcription, Genetic; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2003 |
The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Blotting, Northern; Cells, Cultured; Cloning, Molecular; Down-Regulation; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Receptors, Progesterone; RNA, Messenger; Selective Estrogen Receptor Modulators; Sheep; Stromal Cells; Time Factors; Transforming Growth Factor alpha; Tumor Cells, Cultured; Up-Regulation | 2003 |
Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Fas Ligand Protein; Female; Fulvestrant; Humans; In Situ Nick-End Labeling; Membrane Glycoproteins; Mice; Mice, Nude; Polymerase Chain Reaction; Receptor, ErbB-2; Tamoxifen; Transforming Growth Factor alpha; Transplantation, Heterologous | 2003 |
Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors.
Topics: Animals; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Immunohistochemistry; Incidence; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Transforming Growth Factor alpha | 2009 |
Prolactin activates ERĪ± in the absence of ligand in female mammary development and carcinogenesis in vivo.
Topics: Aging; Animals; Carcinogenesis; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Mutation; Prolactin; Transforming Growth Factor alpha | 2013 |